Our story started in 2008 when Prof. Jouko Yliruusi and Prof. Edward Hæggström first combined their respective expertise in pharmaceutical technology and physics. This extraordinary collaboration produced a novel particle engineering technology with the ability to transform the pharmaceutical industry.
They discovered the Controlled Expansion of Supercritical Solutions (CESS®) process in 2012 at the University of Helsinki and Nanoform was founded in 2015. Since then, Nanoform has expanded rapidly, transforming into a company with global ambition. Our cutting edge nanoforming services is intended to help the global pharmaceutical industry to double its annual new medicines output. We are proud to be a Finnish success story with an international outlook.